Impact of TLR7/8 Triggering on HIV Pathogenesis

Similar documents
Human Immunodeficiency Virus

How HIV Causes Disease Prof. Bruce D. Walker

HIV INFECTION: An Overview

MedChem 401~ Retroviridae. Retroviridae

Fayth K. Yoshimura, Ph.D. September 7, of 7 HIV - BASIC PROPERTIES

Under the Radar Screen: How Bugs Trick Our Immune Defenses

HIV & AIDS: Overview

NK mediated Antibody Dependent Cellular Cytotoxicity in HIV infections

HIV/AIDS. Biology of HIV. Research Feature. Related Links. See Also

Prokaryotic Biology. VIRAL STDs, HIV-1 AND AIDS

HIV Immunopathogenesis. Modeling the Immune System May 2, 2007

Immunodeficiency. (2 of 2)

Fig. 1: Schematic diagram of basic structure of HIV

, virus identified as the causative agent and ELISA test produced which showed the extent of the epidemic

L I F E S C I E N C E S

Fayth K. Yoshimura, Ph.D. September 7, of 7 RETROVIRUSES. 2. HTLV-II causes hairy T-cell leukemia

HIV 101: Fundamentals of HIV Infection

HIV and drug resistance Simon Collins UK-CAB 1 May 2009

Supplementary information. MARCH8 inhibits HIV-1 infection by reducing virion incorporation of envelope glycoproteins

Supporting Information

Running Head: AN UNDERSTANDING OF HIV- 1, SYMPTOMS, AND TREATMENTS. An Understanding of HIV- 1, Symptoms, and Treatments.

Lentiviruses: HIV-1 Pathogenesis

Role of Innate Immunity in Hepatitis B Virus Infection Adam J. Gehring, Ph.D.

Immunity and Infection. Chapter 17

Feb 11, Gene Therapy. Sam K.P. Kung Immunology Rm 417 Apotex Center

Immunity to Viruses. Patricia Fitzgerald-Bocarsly September 25, 2008

levels of genes were separated by their expression levels; 2,000 high, medium, and low

Measles virus vaccine induces oncolysis of tumor cells and activates immune responses.

Human Immunodeficiency Virus

Are we targeting the right HIV determinants?

Combining Pharmacology and Mutational Dynamics to Understand and Combat Drug Resistance in HIV

RAISON D ETRE OF THE IMMUNE SYSTEM:

cure research HIV & AIDS

HIV-1 Dual Infection and Neurocognitive Impairment

CYTOKINE RECEPTORS AND SIGNAL TRANSDUCTION

Herpesviruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics

Section Lectures: Immunology/Virology Time: 9:00 am 10:00 am LRC 105 A & B

Effector Mechanisms of Cell-Mediated Immunity

Acquired immune deficiency syndrome.

Innate Immunity. Connection Between Innate and Adaptive Immunity. Know Differences and Provide Examples Chapter 3. Antimicrobial peptide psoriasin

There are approximately 30,000 proteasomes in a typical human cell Each proteasome is approximately 700 kda in size The proteasome is made up of 3

Lecture on Innate Immunity and Inflammation

Allergy and Immunology Review Corner: Chapter 13 of Immunology IV: Clinical Applications in Health and Disease, by Joseph A. Bellanti, MD.

AGAINST VIRAL INFECTIONS. Identify the types of immunity involve in the mechanisms of protection against viral infections.

La risposta immune all infezione da virus ebola. Chiara Agrati, PhD

HIV 1 exploits innate signaling by TLR8 and DC SIGN for productive infection of dendritic cells

Toll-like Receptors (TLRs): Biology, Pathology and Therapeutics

RAISON D ETRE OF THE IMMUNE SYSTEM:

Laboratory diagnostics CH/HIV/0052/17/10/2017

HIV acute infections and elite controllers- what can we learn?

IAS 2015 Towards an HIV Cure symposium Vancouver Immune recognition following latency reversal

Ebola virus crisis. Prof. Viktor Volchkov. Molecular basis of viral pathogenicity

Therapeutic strategies for immune reconstitution in acquired immunodeficiency syndrome

Habilitation in Experimental Pathology, Medical Faculty, University Hospital

5. Over the last ten years, the proportion of HIV-infected persons who are women has: a. Increased b. Decreased c. Remained about the same 1

MID-TERM EXAMINATION

Newly Recognized Components of the Innate Immune System

Innate Immunity. Chapter 3. Connection Between Innate and Adaptive Immunity. Know Differences and Provide Examples. Antimicrobial peptide psoriasin

Viral Vectors In The Research Laboratory: Just How Safe Are They? Dawn P. Wooley, Ph.D., SM(NRM), RBP, CBSP

VIROLOGY. Engineering Viral Genomes: Retrovirus Vectors

Innate immunity. Abul K. Abbas University of California San Francisco. FOCiS

1. TLR. TLR Toll-like receptors. Toll Toll-like receptor, TLR TLR TLR TLR. type I TLR TLR. Toll

Diagnostic Tests for HIV

HUMAN IMMUNODEFICIENCY VIRUS

Human Immunodeficiency Virus. Acquired Immune Deficiency Syndrome AIDS

Inves)gación básica y curación del VIH- 1

7.013 Spring 2005 Problem Set 7

Immunologic Methods in Diagnosis of HIV Infection. Tehran Medical Sciences Branch, Islamic Azad


Scott Abrams, Ph.D. Professor of Oncology, x4375 Kuby Immunology SEVENTH EDITION

T-Pharmacytes for the Targeted Eradication of HIV Reservoirs

IMO-8400, a novel TLR7, TLR8 and TLR9 antagonist, psoriasis

The IL-7 Receptor A Key Factor in HIV Pathogenesis

Innate and Cellular Immunology Control of Infection by Cell-mediated Immunity

LESSON 4.6 WORKBOOK. Designing an antiviral drug The challenge of HIV

HIV AND INFLAMMATION: A NEW THREAT

MID 36. Cell. HIV Life Cycle. HIV Diagnosis and Pathogenesis. HIV-1 Virion HIV Entry. Life Cycle of HIV HIV Entry. Scott M. Hammer, M.D.

Citation for published version (APA): Von Eije, K. J. (2009). RNAi based gene therapy for HIV-1, from bench to bedside

Antigen Presentation and T Lymphocyte Activation. Abul K. Abbas UCSF. FOCiS

Hepatitis virus immunity. Mar 9, 2005 Rehermann and Nascimbeni review Crispe review

HCV eradication with direct acting antivirals (DAAs)? Why is viral cure possible in HCV? Emilie Estrabaud

VIRUSES AND CANCER Michael Lea

CURRENT DEVELOMENTS AND FUTURE PROSPECTS FOR HIV GENE THERAPY USING INTERFERING RNA-BASED STRATEGIES

Defense Against Viruses/AIDS. Shomyseh Sanjabi, PhD Micro 204, 12/01/17

Progressive Multifocal Leukoencephalopathy (PML)

Induction and Clearance of Latent HIV Infection:

Retroviruses. ---The name retrovirus comes from the enzyme, reverse transcriptase.

Can HPV, cervical neoplasia or. HIV transmission?

For all of the following, you will have to use this website to determine the answers:

Recombinant Protein Expression Retroviral system


A PROJECT ON HIV INTRODUCED BY. Abdul Wahab Ali Gabeen Mahmoud Kamal Singer

1. The scavenger receptor, CD36, functions as a coreceptor for which TLR? a. TLR ½ b. TLR 3 c. TLR 4 d. TLR 2/6

Nature Medicine: doi: /nm.2109

4. Th1-related gene expression in infected versus mock-infected controls from Fig. 2 with gene annotation.

International Journal of PharmTech Research CODEN (USA): IJPRIF, ISSN: , ISSN(Online): Vol.9, No.12, pp , 2016

Retroviruses (family Retroviridae) are enveloped, single stranded (+) RNA viruses. members that are oncogenic, are associated

SUPPLEMENTARY INFORMATION

08/02/59. Tumor Immunotherapy. Development of Tumor Vaccines. Types of Tumor Vaccines. Immunotherapy w/ Cytokine Gene-Transfected Tumor Cells

ACQUIRED IMMUNODEFICIENCY SYNDROME AND ITS OCULAR COMPLICATIONS

Transcription:

University Hospital Zurich u Division of Infectious Diseases and Hospital Epidemiology Impact of TLR7/8 Triggering on HIV Pathogenesis Roberto F. Speck, MD

Hallmark of HIV-Infection is the Progressive CD4+ T-Cell Loss Acute HIV infection Death CD4+ T-cells/μl Clinical latency HIV RNA copies/ml Weeks Years

HIV Single Stranded RNA (ssrna) Triggers TLR8 Heil F et al., Science 2004

HIV ssrna which Act as TLR7/8 Agonists are Rich in Guanosins and Uridins Multiple fragments within the HIV genome U3 RU5 gag pol vif vpr tat rev vpu env nef

Multiple Fragments within the HIV Genome U3 RU5 gag pol vif vpr tat rev vpu env nef Meier A. et al., J Virol 2007

Questions What is the effect of TLR7/8 triggering 1. on acute HIV infection? 2. on latently infected cells? 3. on the immune system?

HIV ssrna Blocks HIV Replication in Ex Vivo Infected Lymphoid Tissue sshiv ssrna synthetic compounds HIV infection Monitoring of HIV replication over 10-14 d Lymphatic tissue ng p24/ml 10 5 control unspecific ssrna42 Schlaepfer et al., 2006 J Immunol 0 0 2 4 6 days post infection HIV ssrna 40

DC and NK/CD8+ T-Cells are Key for the TLR7/8 Mediated Resistance to HIV Replication DC control TLR7/8 stimulation HIV replication relative to ctrl 3 2 1 0 NK SSC control TLR7/8 stimulation 0.55 24.33 IFN-γ 0.98 2.02 TNF-α Schlaepfer and Speck; Plos One 2008 HIV HIV replication relative to control 1.5 1.0 0.5 0.0 control Control control TLR7/8 stimulation p<0.005 TLR7/8 stimulation TLR7/8 stimulation DC TLR7/8 stimulation CD8+/NK

TLR7/8 triggering by HIV ssrna immune system? CD4 M CD4 CD4 CD4? latent reservoir HIV replication chronic HIV infection

TLR7/8 Triggering Results in the Activation of and Release of HIV from Latently Infected Myeloid- Monocytoid Cells TLR7/8 stimulation 20 latently infected cells % p24+ cells 15 10 5 TLR7/8 stimulation Mock-treated 0 0 1 2 3 days post-stimulation days after TLR7/8 triggering Schlaepfer et al. J Immunol, 2006

TLR7/8 triggering by HIV ssrna CD4 M CD4 CD4 CD4 latent reservoir HIV replication chronic HIV infection

What Happens when there is Sustained Triggering of the TLR7/8 Pathway? Death Acute HIV infection HIV RNA Kopien/ml copies/ml Clinical latency CD4+ T-cells/μl T-Zellen/μl

HIV is a Human Specific Virus Daily injections i.p. of R-848 C57BL/6 mice... [time] complete blood count cytokines histopathology functional assays (VSV)

Sustained Triggering TLR7 Results in CD4+ Cell decline in Peripheral Blood of Mice Baenziger S et al., Blood 2009

Triggering TLR7 in Mice Results in Dose- Dependent Immune Activation R-848 HIV+patients CD69 % Onlamoon N et al., Virology 2005

IFN type I has Properties Stimulating Immune Activation

Sustained Triggering TLR7 Disrupts the Lymphoid Architecture mock polyi:c R-848 0.01 mg 0.1 mg 1 mg Baenziger S et al., Blood 2009

Functionally, Triggering TLR7 Results in Poor Antigen-Specific Antibody Response Baenziger S et al., Blood 2009

HIV ssrna Induces all the Features Characteristic of HIV Infection Uncoupled from Productive HIV Infection

HIV ssrna Triggering TLR7/8 Nef U3 RU5 gag pol vif vpr HIV env gp120 tat rev vpu env nef Activation of the immune system Loss of integrity of the GI-tract Inward flux of microbial components Disruption of the lymphoid system and CD4+ T-cell loss Immundeficiency AIDS Death

Level of Immune Activation is the Best Predictor for HIV Progression Froebel K et al., Clin Exp Immunol 2001

TLR7/8 triggering by HIV ssrna Dysfunction of the immune system CD4 M CD4 CD4 CD4 latent reservoir HIV replication chronic HIV infection

Thanks Labor - Erika Schläpfer - Stefan Bänziger - Annette Audigé - Regina Miller - Ursula Hofer - Florian Blaser - Marc Nischang Institute of Neuropathology, USZ - Prof. Adriano Aguzzi - Mathias Heikenwälder EMDO Stiftung Empiris Stiftung OPO Stiftung

The molecular mechanism(s) resulting in CD4+ T-cell death in HIV Infection is still unknown 1. HIV binds to, infects, and kills CD4+ T-cells. 2. progressive CD4+ T-cell depletion follows HIV infection. 3. the prevailing level of viral replication predicts the in vivo rate of CD4+ T-cell depletion. 4. the pharmacologic suppression of viral replication is followed by an increase in CD4+ T-cell counts. HIV-mediated direct killing of CD4+ T-cells

Speck RF et al, J of Virol 1998 HIV is highly cytopathic in vitro, but... Speck RF et al., J Virol 1998

but... < 0.1% of CD4+ T-cells infected with HIV in chronic HIV infection. majority of CD4+ T-cells that die, are in fact not infected.

Genomic structure of HIV is quite simple U3 RU5 gag Long-terminal repeat pol vif vpr tat rev vpu env Env Surface glycoprotein nef Env Transmembrane gp41 Gag Membrane associated (Matrix) protein Gag Capsid RNA Pol Polymerase Protease RNAse H Integrase

TLR7/8 Aktivierung hat multiple Effekte auf die HIV Pathogenese NK TLR7/8 Signal Aktivierung CD8 Immunaktivierung CD4 M CD4 CD4 CD4 HIV Replikation Immunschwäche Aktivierung des Latenten Reservoirs: HIV Freisetzung Chronische HIV Infektion

What other evidence do we have that our theory is correct? Mandl JN et al, Nature Medicine 2008

Viren müssen Wirtszellen infizieren, um sich zu vermehren zur Verfügung gestellt von Prof. A. Oxenius

Cleavage of the ectodomain 9 is required to generate a functional receptor Ewald SE et al, Nature 2008

Genomic structure of HIV is quite simple HIV genome Long-terminal repeat U3 RU5 gag pol vif vpr tat rev vpu env nef U3 R U5

TLR belong to the pattern recognition receptors Toll-like receptors (TLR) recognition domain out cell membrane in signaling box

Currently, 11 Toll-like Receptors are Known Foo Y et al., Nature Reviews Immunology, 2005

Reasons for immuno-activation in HIV infection Schindler M et al., Cell 2006

Reasons for immuno-activation in HIV infection HIV envelope gp120 aberrant signaling exchange of lipids (env+ cells & env- cell) syncytia induction contagious apoptosis Reviewed by Perfettini JL et al, Cell death and Differentiation, 2005)

HIV envelope gp120 results in abberrant signaling and subsequently in apoptosis gp120

Microbial translocation may contribute ot immune activation in HIV infection Brenchley et al, Nat Med, 2006

Triggering Toll-like receptor (TLR) 7/8 results in strong activation of the immune system Kontrolle Aktivierung der Toll-like Rezeptoren Toll-like Rezeptoren 7/8 Schlaepfer E. and Speck RF; Plos One 2008

Foster JL and JV Garcia, Retrovirology 2008

Direkte HIV Infektion (Zytopathizität; vorzugsweise Infektion von HIV-spezifischen CD4+ Memory Zellen) CD8+ T-Zell vermittelte Zytopathizität HIV envelope gp120 induzierter Zelltod CD4+ Zelle Chronische Immunaktivierung Progressiver CD4+ T-Zellabfall

Depleting dendritic cells (DC) or natural killer (NK) and CD8+ cells abolishes TLR7/8-mediated inhibition of HIV replication DC Control TLR7/8 triggering HIV replication relative HIV replication to control relative to ctrl 3 2 1 0 NK Control TLR7/8 triggering TLR7/8 triggering DC control TLR7/8 triggering p<0.005 Submitted SSC 0.55 24.33 IFN-γ 0.98 2.02 TNF-α HIV HIV replication relative to control 1.5 1.0 0.5 0.0 Control Control TLR7/8 triggering TLR7/8 triggering CD8+ and NK cells

Akira S, Cell 2006 Effective immune response

Lethal Encephalitis in MyD88 - / - Mice Infected with Herpes Simplex Virus 1 Wildtype / TLR2 - / - MyD88 - / - IFN-γ - / - Mansur et al., AJP 2005

Triggering TLR7 results in splenomegaly

Cytokine pattern does not differ between mice treated with polyi:c or R-848

Only partial tolerance induction in mice injected R-848 over time IL-6 IL12p40 IL-10 TNF-a

Schematic Structure of TLR recognition domain out cell membrane in signaling box

HIV Leads to a Sustained Immune Activation %CD38+ CD8+ T-cells Regina Miller, unpublished data